Abstract
Major depressive disorder (MDD) is characterized as clinical depression, which primarily affects the mood and behaviour of an individual. In the present study butyrylcholinesterase (BChE), a co-regulatory cholinergic neurotransmitter enzyme implicated in several putative neuronal and non-neuronal physiological roles was investigated for its role in MDD. Eighty MDD patients and sixty-one healthy controls were recruited for the study. BChE activity was measured by Ellman’s method using serum while DNA samples of the patients were genotyped for BCHE polymorphisms rs3495 (c.*189G > A) and rs1803274 (c.1699G > A) by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) and tetra-primer Amplification Refractory Mutation System- polymerase chain reaction (ARMS-PCR). The genotyping was further validated by Sanger Sequencing. Biochemical estimation of serum BChE levels revealed a statistically significant decrease of enzyme activity in MDD patients (69.96) as compared to healthy controls (90.97), which was independent of age and gender. BCHE single nucleotide polymorphism rs1803274 genotype GA was found to be associated with the disease under a dominant model (OR 2.32; 95% CI 1.09–4.96; p value = 0.025). Furthermore, risk allele-A frequency was higher in cases (p value = 0.013) than control. Carriers of rs1803274 GA genotype showed reduced mean BChE activity than wild-type allele GG homozygotes (p value = 0.040). Gender-based analysis revealed a protective role of rs3495 in females (χ2 = 6.87, p value = 0.032, RM: OR 0.173, CI = 0.043–0.699 (p value = 0.017). In addition, rs1803274 risk allele-A was observed to be significantly higher in males (χ2 = 4.258, p value = 0.039). In conclusion, the present study is indicative of a role of BChE in the pathophysiology of MDD where genetic polymorphisms were observed to effect BChE activity. Further replication studies in different ethnicities are recommended to validate the current observations.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Data Availability
Available on request.
Code Availability
Available on request.
References
aan het Rot M, Mathew SJ, Charney DS (2009) Neurobiological mechanisms in major depressive disorder. Can Med Assoc J 180(3):305–313. https://doi.org/10.1503/cmaj.080697
Adler M, Sweeney RE, Hamilton TA, Lockridge O, Duysen EG, Purcell AL, Deshpande SS (2011) Role of acetylcholinesterase on the structure and function of cholinergic synapses: insights gained from studies on knockout mice. Cell Mol Neurobiol 31:909–920
Aeinehband S, Lindblom RPF, Al Nimer F, Vijayaraghavan S, Sandholm K, Khademi M, Olsson T, Nilsson B, Ekdahl KN, Darreh-Shori T, Piehl F (2015) Complement component C3 and butyrylcholinesterase activity are associated with neurodegeneration and clinical disability in multiple sclerosis. PLoS ONE 10(4):e0122048. https://doi.org/10.1371/journal.pone.0122048
Albert PR (2015) Why is depression more prevalent in women? J Psychiatry Neurosci 40(4):219–221. https://doi.org/10.1503/jpn.150205
Alvarez-Arcaya A, Combarros O, Llorca J, Sanchez-Guerra M, Berciano J, FernandezViadero C, Pena N (2000) The butyrylcholinesterase K variant is a protective factor for sporadic Alzheimer’s disease in women. Acta Neurol Scand 102(6):350–353. https://doi.org/10.1034/j.1600-0404.2000.102006350.x
Berger PA (1981) Biochemistry and the schizophrenia: old concepts and new hypothesis. J Nerv Ment Dis 169(2):90–99
Bono GF, Simão-Silva DP, Batistela MS, Josviak ND, Dias PFR, Nascimento GA, Souza RLR, Piovezan MR, Souza RKM, Furtado-Alle L (2015) Butyrylcholinesterase: K variant, plasma activity, molecular forms and rivastigmine treatment in Alzheimer’s disease in a Southern Brazilian population. Neurochem Int 81:57–62. https://doi.org/10.1016/j.neuint.2014.12.009
Breslend NL, Parent J, Forehand R, Peisch V, Compas BE (2017) Children of parents with a history of depression: the impact of a preventive intervention on youth social problems through reductions in internalizing problems. Dev Psychopathol. https://doi.org/10.1017/S0954579417001821
Bretlau C, Kryspin Soerensen M, Zimling Vedersoe A-L, Simon Rasmussen L, Ring Gätke M (2013) Response to succinylcholine in patients carrying the K-variant of the butyrylcholinesterase gene. Anesth Analg 116(3):596–601. https://doi.org/10.1213/ANE.0b013e318280a3f3
Brimijoin S, Tye S (2017) Favorable impact on stress-related behaviors by modulating plasma butyrylcholinesterase. Cell Mol Neurobiol. https://doi.org/10.1007/s10571-017-0523-z
Brimijoin S, Chen VP, Pang Y-P, Geng L, Gao Y (2016) Physiological roles for butyrylcholinesterase: a BChE-ghrelin axis. Chem Biol Interact 259:271–275. https://doi.org/10.1016/j.cbi.2016.02.013
Chen KH, Reese EA, Kim H-W, Rapoport SI, Rao JS (2011) Disturbed neurotransmitter transporter expression in Alzheimer’s disease brain. J Alzheimer’s Dis 26(4):755–766. https://doi.org/10.3233/JAD-2011-110002
Chen VP, Gao Y, Geng L, Parks RJ, Pang Y-P, Brimijoin S (2015) Plasma butyrylcholinesterase regulates ghrelin to control aggression. Proc Natl Acad Sci USA 112(7):2251–2256. https://doi.org/10.1073/pnas.1421536112
Corvin A, Donohoe G, Hargreaves A, Gallagher L, Gill M (2011) The cognitive genetics of neuropsychiatric disorders. In: Cryan JF, Reif A (eds) Behavioral neurogenetics, vol 12. Springer Berlin Heidelberg, Berlin, Heidelberg, pp 579–613. https://doi.org/10.1007/7854_2011_188
Darvesh S, Hopkins DA, Geula C (2003) Neurobiology of butyrylcholinesterase. Nat Rev Neurosci 4(2):131–138. https://doi.org/10.1038/nrn1035
de Oliveira J, Tureck LV, dos Santos W, Saliba LF, Schenknecht CS, Scaraboto D, Souza RLR, Furtado-Alle L (2017) Effect of BCHE single nucleotide polymorphisms on lipid metabolism markers in women. Genet Mol Biol 40(2):408–414. https://doi.org/10.1590/1678-4685-gmb-2016-0123
Deutsch SI, Campbell M (1984) Status of cholinesterase activities in blood in neuropsychiatric disorders. Neurochem Res 9(7):863–869
Dhananjayan V, Ravichandran B, Anitha N, Rajmohan HR (2012) Assessment of acetylcholinesterase and butyrylcholinesterase activities in blood plasma of agriculture workers. Indian J Occup Environ Med 16(3):127–130. https://doi.org/10.4103/0019-5278.111755
Dilsaver SC, Coffman JA (1989) Cholinergic hypothesis of depression: a reappraisal. J Clin Psychopharmacol 9(3):173–179
Dingova D, Fazekas T, Okuliarova P, Strbova J, Kucera M, Hrabovska A (2016) Low plasma cholinesterase activities are associated with deficits in spatial orientation, reduced ability to perform basic activities of daily living, and low body mass index in patients with progressed Alzheimer’s disease. J Alzheimer’s Dis 51(3):801–813. https://doi.org/10.3233/JAD-151060
Ellman GL, Courtney KD, Andres V, Feather-Stone RM (1961) A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7:88–95
Ezzaher A, Haj Mouhamed D, Mechri A, Neffati F, Douki W, Gaha L, Najjar MF (2012) Pseudocholinesterase activity in type 1 bipolar patients. Ann Biol Clin 70(1):25–31. https://doi.org/10.1684/abc.2011.0652
Fiocco AJ, Nair NPV, Schwartz G, Kin FNY, Joober R, Poirier J, Lupien SJ (2009) Influence of genetic polymorphisms in the apolipoprotein (APOE) and the butyrylcholinesterase (BCHE) gene on stress markers in older adults: a 3-year study. Neurobiol Aging 30(6):1001–1005. https://doi.org/10.1016/j.neurobiolaging.2007.09.008
Furtado-Alle L, Andrade FA, Nunes K, Mikami LR, Souza RLR, Chautard-Freire-Maia EA (2008) Association of variants of the −116 site of the butyrylcholinesterase BCHE gene to enzyme activity and body mass index. Chem Biol Interact 175(1–3):115–118. https://doi.org/10.1016/j.cbi.2008.04.019
Gätke MR, Viby-Mogensen J, Ostergaard D, Bundgaard JR (2005) Response to mivacurium in patients carrying the k variant in the butyrylcholinesterase gene. Anesthesiology 102(3):503–508
Gavin AR, Walton E, Chae DH, Alegria M, Jackson JS, Takeuchi D (2010) The associations between socioeconomic status and major depressive disorder among Blacks, Latinos, Asians, and Non-Hispanic Whites: findings from the Collaborative Psychiatric Epidemiology Studies. Psychol Med 40(1):51–61. https://doi.org/10.1017/S0033291709006023
Gold JH (1998) Gender differences in psychiatric illness and treatments: a critical review. J Nerv Ment Dis 186(12):769–775
Green MR, Sambrook J (2017) Isolation of high-molecular-weight DNA using organic solvents. Cold Spring Harbor Protoc 2017(4):pdb.prot093450. https://doi.org/10.1101/pdb.prot093450
Jacob CP, Weber H, Retz W, Kittel-Schneider S, Heupel J, Renner T, Lesch K-P, Reif A (2013) Acetylcholine-metabolizing butyrylcholinesterase (BCHE) copy number and single nucleotide polymorphisms and their role in attention-deficit/hyperactivity syndrome. J Psychiatr Res 47(12):1902–1908. https://doi.org/10.1016/j.jpsychires.2013.08.006
Janowsky D, Davis J, El-Yousef MK, Sekerke HJ (1972) A cholinergic-adrenergic hypothesis of mania and depression. Lancet 300(7778):632–635. https://doi.org/10.1016/S0140-6736(72)93021-8
Johnson G, Moore SW (2012) Why has butyrylcholinesterase been retained? Structural and functional diversification in a duplicated gene. Neurochem Int 61(5):783–797. https://doi.org/10.1016/j.neuint.2012.06.016
Josviak ND, Batistela MS, Souza RKM, Wegner NR, Bono GF, Sulzbach CD, Simão-Silva DP, Piovezan MR, Souza RLR, Furtado-Alle L (2017) Plasma butyrylcholinesterase activity: a possible biomarker for differential diagnosis between Alzheimer’s disease and dementia with Lewy bodies? Int J Neurosci 127(12):1082–1086. https://doi.org/10.1080/00207454.2017.1329203
Kendler KS, Kessler RC, Walters EE, MacLean C, Neale MC, Heath AC, Eaves LJ (1995) Stressful life events, genetic liability, and onset of an episode of major depression in women. Am J Psychiatry 152(6):833–842. https://doi.org/10.1176/ajp.152.6.833
Kendler KS, Kuhn JW, Prescott CA (2004) Childhood sexual abuse, stressful life events and risk for major depression in women. Psychol Med 34(8):1475–1482
Kessing LV, Bukh JD (2013) Genetics and stressful life events interact in depression. Ugeskr Laeger 175(14):948–951
Lima JK, Leite N, Turek LV, Souza RLR, da Silva Timossi L, Osiecki ACV, Osiecki R, Furtado-Alle L (2013) 1914G variant of BCHE gene associated with enzyme activity, obesity and triglyceride levels. Gene 532(1):24–26
Lockridge O (2015) Review of human butyrylcholinesterase structure, function, genetic variants, history of use in the clinic, and potential therapeutic uses. Pharmacol Ther 148:34–46. https://doi.org/10.1016/j.pharmthera.2014.11.011
Lockridge O, Norgren RB, Johnson RC, Blake TA (2016) Naturally occurring genetic variants of human acetylcholinesterase and butyrylcholinesterase and their potential impact on the risk of toxicity from cholinesterase inhibitors. Chem Res Toxicol 29(9):1381–1392. https://doi.org/10.1021/acs.chemrestox.6b00228
Lohoff FW (2010) Overview of the genetics of major depressive disorder. Curr Psychiatry Rep 12(6):539–546. https://doi.org/10.1007/s11920-010-0150-6
Lorant V (2003) Socioeconomic inequalities in depression: a meta-analysis. Am J Epidemiol 157(2):98–112. https://doi.org/10.1093/aje/kwf182
Lushchekina S, Delacour H, Lockridge O, Masson P (2015) Human butyrylcholinesterase polymorphism: molecular modeling. Int J Risk Saf Med 27(s1):S80–S81. https://doi.org/10.3233/JRS-150699
Manji HK, Quiroz JA, Payne JL, Singh J, Lopes BP, Viegas JS, Zarate CA (2003) The underlying neurobiology of bipolar disorder. World Psychiatry 2(3):136–146
Martin EI, Ressler KJ, Binder E, Nemeroff CB (2009) The neurobiology of anxiety disorders: brain imaging, genetics, and psychoneuroendocrinology. Psychiatr Clin North Am 32(3):549–575. https://doi.org/10.1016/j.psc.2009.05.004
McIlroy SP (2000) Butyrylcholinesterase K variant is genetically associated with late onset Alzheimer’s disease in Northern Ireland. J Med Genet 37(3):182–185. https://doi.org/10.1136/jmg.37.3.182
McLaughlin KA, Conron KJ, Koenen KC, Gilman SE (2010) Childhood adversity, adult stressful life events, and risk of past-year psychiatric disorder: a test of the stress sensitization hypothesis in a population-based sample of adults. Psychol Med 40(10):1647–1658. https://doi.org/10.1017/S0033291709992121
Modai I, Schwartz B, Aizenberg D (1987) Serum pseudocholinesterase in psychiatric patients. Biol Psychiatry 22(10):1238–1242
Monroe SM, Slavich GM, Gotlib IH (2014) Life stress and family history for depression: the moderating role of past depressive episodes. J Psychiatr Res 49:90–95. https://doi.org/10.1016/j.jpsychires.2013.11.005
Oguri M, Kato K, Yokoi K, Yoshida T, Watanabe S, Metoki N, Yoshida H, Satoh K, Aoyagi Y, Tanaka M, Nozawa Y, Yamada Y (2009) Association of a polymorphism of BCHE with ischemic stroke in Japanese individuals with chronic kidney disease. Mol Med Rep 2(5):779–785. https://doi.org/10.3892/mmr_00000172
Pezzementi L, Nachon F, Chatonnet A (2011) Evolution of acetylcholinesterase and butyrylcholinesterase in the vertebrates: an atypical butyrylcholinesterase from the medaka Oryzias latipes. PLoS ONE 6(2):e17396. https://doi.org/10.1371/journal.pone.0017396
Podoly E, Shalev DE, Shenhar-Tsarfaty S, Bennett ER, Ben Assayag E, Wilgus H, Livnah O, Soreq H (2009) The butyrylcholinesterase K variant confers structurally derived risks for Alzheimer pathology ♦. J Biol Chem 284(25):17170–17179. https://doi.org/10.1074/jbc.M109.004952
Pongthanaracht N, Yanarojana S, Pinthong D, Unchern S, Thithapandha A, Assantachai P, Supavilai P (2017) Association between butyrylcholinesterase K variant and mild cognitive impairment in the Thai community-dwelling patients. Clin Interv Aging 12:897–901. https://doi.org/10.2147/CIA.S137264
Riemann D, Hohagen F, Bahro M, Lis S, Stadmüller G, Gann H, Berger M (1994) Cholinergic neurotransmission, REM sleep and depression. J Psychosom Res 38(Suppl 1):15–25
Salvadore G, Quiroz JA, Machado-Vieira R, Henter ID, Manji HK, Zarate CA (2010) The neurobiology of the switch process in bipolar disorder: a review. J Clin Psychiatry 71(11):1488–1501. https://doi.org/10.4088/JCP.09r05259gre
Scott KM, Collings SCD (2010) Gender and the association between mental disorders and disability. J Affect Disord 125(1–3):207–212. https://doi.org/10.1016/j.jad.2010.06.022
Serretti A, Chiesa A, Calati R, Linotte S, Sentissi O, Papageorgiou K, Kasper S, Zohar J, De Ronchi D, Mendlewicz J, Amital D, Montgomery S, Souery D (2013) Influence of family history of major depression, bipolar disorder, and suicide on clinical features in patients with major depression and bipolar disorder. Eur Arch Psychiatry Clin Neurosci 263(2):93–103. https://doi.org/10.1007/s00406-012-0322-y
Shapero BG, Black SK, Liu RT, Klugman J, Bender RE, Abramson LY, Alloy LB (2014) Stressful life events and depression symptoms: the effect of childhood emotional abuse on stress reactivity: child emotional abuse and stress sensitization. J Clin Psychol 70(3):209–223. https://doi.org/10.1002/jclp.22011
Thakar JH, Lapierre YD, Waters BG (1985) Cholinesterases in primary affective disorders. Clin Biochem 18(5):308–310
Tsuang MT, Taylor L, Faraone SV (2004) An overview of the genetics of psychotic mood disorders. J Psychiatr Res 38(1):3–15
Uher R (2014) Gene–environment interactions in severe mental illness. Front Psychiatry. https://doi.org/10.3389/fpsyt.2014.00048
Vaisi-Raygani A, Rahimi Z, Entezami H, Kharrazi H, Bahrhemand F, Tavilani H, Rezaei M, Kiani A, Nomanpour B, Pourmotabbed T (2008) Butyrylcholinesterase K variants increase the risk of coronary artery disease in the population of western Iran. Scand J Clin Lab Investig 68(2):123–129. https://doi.org/10.1080/00365510701576180
Wang Z, Jiang Y, Wang X, Du Y, Xiao D, Deng Y, Wang J (2015) Butyrylcholinesterase K variant and Alzheimer’s disease risk: a meta-analysis. Med Sci Monit 21:1408–1413. https://doi.org/10.12659/MSM.892982
Worek F, Mast U, Kiderlen D, Diepold C, Eyer P (1999) Improved determination of acetylcholinesterase activity in human whole blood. Clin Chim Acta 288(1):73–90. https://doi.org/10.1016/S0009-8981(99)00144-8
Ye S, Humphries S, Green F (1992) Allele specific amplification by tetra-primer PCR. Nucleic Acids Res 20(5):1152
Acknowledgements
We would like to thank all the patients and their families for participation in the current study.
Funding
Core grant of COMSATS University Islamabad.
Author information
Authors and Affiliations
Contributions
SA, ANH: data and sample collection, sample processing, and genotyping, first draft of the manuscript. RT: patient clinical diagnosis, clinical data, and sample collection. SM, RH, SB: data analysis, manuscript editing. SMN, RQ, MA: study design, provision of funds, data analysis, and manuscript finalization.
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical Approval
The Ethics Review Board of The Department of Biosciences, COMSATS University Islamabad, approved the study, the study conformed to the Helsinki declaration.
Consent to Participate
Each of the study participants was informed about the purpose of the research and written consent was obtained from all the subjects before sample collection.
Consent for Publication
Each of the authors mentioned in the manuscript have consented for authorship, read and accepted the manuscript, also provided permission for data sharing and publication of the manuscript.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Awan, S., Hashmi, A.N., Taj, R. et al. Genetic Association of Butyrylcholinesterase with Major Depressive Disorder. Biochem Genet 60, 720–737 (2022). https://doi.org/10.1007/s10528-021-10125-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10528-021-10125-z